These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22563750)

  • 1. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope W;
    Clin Microbiol Infect; 2012 Jul; 18(7):E246-7. PubMed ID: 22563750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.
    Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)
    Clin Microbiol Infect; 2008 Apr; 14(4):398-405. PubMed ID: 18190574
    [No Abstract]   [Full Text] [Related]  

  • 4. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
    Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
    Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUCAST technical note on Amphotericin B.
    Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
    Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
    Clin Microbiol Infect; 2012 Jul; 18(7):E248-50. PubMed ID: 22540149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.
    Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
    Clin Microbiol Infect; 2008 Oct; 14(10):982-4. PubMed ID: 18828858
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test.
    Gutierrez-Galhardo MC; Zancopé-Oliveira RM; Monzón A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Mycoses; 2010 May; 53(3):227-31. PubMed ID: 19389067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUCAST technical note on anidulafungin.
    Arendrup MC; Rodriguez-Tudela JL; Lass-Flörl C; Cuenca-Estrella M; Donnelly JP; Hope W;
    Clin Microbiol Infect; 2011 Nov; 17(11):E18-20. PubMed ID: 21923778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).
    Rodriguez-Tudela JL; Donnelly JP; Pfaller MA; Chryssantou E; Warn P; Denning DW; Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M
    J Clin Microbiol; 2007 Jan; 45(1):109-11. PubMed ID: 17093015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.
    Espinel-Ingroff A; Turnidge J
    Rev Iberoam Micol; 2016; 33(2):63-75. PubMed ID: 27296911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUCAST technical note on posaconazole.
    Arendrup MC; Cuenca-Estrella M; Donnelly JP; Hope W; Lass-Flörl C; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2011 Nov; 17(11):E16-7. PubMed ID: 21923779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL
    Clin Microbiol Infect; 2005 Jun; 11(6):486-92. PubMed ID: 15882199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro methods for antifungal susceptibility testing of Trichophyton spp.
    Barros ME; Santos Dde A; Hamdan JS
    Mycol Res; 2006 Nov; 110(Pt 11):1355-60. PubMed ID: 17070026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dimethyl sulfoxide and water as solvents for echinocandin susceptibility testing by the EUCAST methodology.
    Alastruey-Izquierdo A; Gómez-López A; Arendrup MC; Lass-Florl C; Hope WW; Perlin DS; Rodriguez-Tudela JL; Cuenca-Estrella M
    J Clin Microbiol; 2012 Jul; 50(7):2509-12. PubMed ID: 22535988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antifungal susceptibility testing using CLSI reference and commercial methods.
    Cantón E; Espinel-Ingroff A; Pemán J
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):107-19. PubMed ID: 19622060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
    Cuenca-Estrella M; Rodriguez-Tudela JL
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.